PDS Biotechnology Stock Gets Nasdaq Extension as Traders Eye PDSB
PDS Biotechnology shares closed at $1.16 Tuesday after Nasdaq confirmed the company regained compliance with its $1 minimum bid rule, ending a delisting threat. The stock had traded under $1 for 30 days earlier this year. PDSB’s market value stands at about $64 million. The company continues to face clinical trial and financing risks.